Personalized Vaccine May Help Reverse Moles, Offering Hope for Cancer Prevention and Cosmetic Removal
Scientists at the Frances Crick Institute have developed a personalized vaccine that may enable the self-destruction of moles, potentially paving the way for a new treatment to reverse moles in patients at heightened risk of cancer and a new form of cosmetic removal.
The vaccine targets the NRAS gene, which is mutated in mole cells and can predispose people to cancer.
The research, conducted in collaboration with Great Ormond Street Hospital (GOSH), has shown promising results in both cell cultures and mice.
Also Read: Adekunle Gold Champions Better Healthcare for Sickle Cell Patients
The vaccine uses silencing RNA, delivered directly into mole cells, to silence the mutated NRAS gene, causing the cells to self-destruct.
The therapy has been tested on cells and skin sections from children with congenital melanocytic naevus syndrome (CMN), a rare skin condition that can result in up to 80% of a person's body being covered in large, painful, or itchy moles and increases the risk of developing melanoma.
Veronica Kinsler, a professor at the Crick and GOSH, expressed excitement about the results, stating that they suggest the potential to reverse moles in people. However, she emphasized that more testing is needed before the treatment can be given to patients.
The research, funded by the National Institute for Health and Care Research (NIHR) and supported by Caring Matters Now, has brought hope to individuals living with CMN.
Jodi Whitehouse, from Caring Matters Now, described the breakthrough as awe-inspiring and exciting, offering real hope to those living with CMN.
Catriona Crombie, Head of Rare Disease at LifeArc, highlighted the organization's commitment to improving the lives of people living with rare diseases by investing in promising research and helping scientists overcome translational research barriers.
The researchers are hopeful that the therapy will soon enter clinical trials on people, potentially revolutionizing the treatment of moles and reducing the risk of skin cancer.
